Tiffany Morgan, MD
Radiation Oncology · Wilmington, NCNPI 1578981676
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (34.4%), travel and lodging and gifts — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Fujifilm Healthcare Americas Corporation at 37.2% of the total. Reporting peaked in 2020 at $1,419 and has fallen 93.5% since, to $92 in 2025.
Across 17 payments — averaging $114.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Fujifilm Healthcare Americas Corporation$723
- Medtec LLC$602
- Novocure Inc.$292
- Monteris Medical Corporation$124
- AstraZeneca$68
- Merck$35
- plus $101 from 4 others
What the payments were for
- Travel & lodging$60631%
- Food & beverage$66934%
- Education$684%
- Gifts$60231%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Fujifilm Healthcare Americas Corporation | 5 | $723 |
| Medtec LLC | 1 | $602 |
| Novocure Inc. | 4 | $292 |
| Monteris Medical Corporation | 1 | $124 |
| AstraZeneca | 1 | $68 |
| Merck | 1 | $35 |
| Progenics Pharmaceuticals, Inc. | 1 | $29 |
| Bayer | 1 | $24 |
| Teleflex LLC | 1 | $24 |
| GT Medical Technologies, Inc | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DR & CR Products & Accessories$606
- Optune$129
- Neuroblate$124
How this compares
$1,945 in reported general payments places this provider in the 75th percentile of 199 radiation oncology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dexamethasone | 22 | $569 |
| Tamsulosin Hcl | 25 | $273 |
| Lidocaine Hcl ViscousLidocaine Hcl | 13 | $130 |
| Oxycodone Hcl | 17 | $123 |
| Pantoprazole Sodium | 22 | $114 |
| Ondansetron Hcl | 12 | $68 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Wilmington
- Michael PapagikosWilmington$51K
- Rex KiteleyWilmington$2K
- Mustafa AbugideiriWilmington$1K
- Andrew WangChapel Hill$118K
- Volker StieberWinston Salem$99K
- Lewis SulmanDurham$54K
- William LeeDurham$37K
- Matthew ManningGreensboro$33K
- Michael ChanWinston Salem$32K
- John KirkpatrickDurham$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.